Status:
COMPLETED
Effect of IDEA-070 on Pain and Inflammation Induced by PDT
Lead Sponsor:
IDEA AG
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
Primary objectives: effect of IDEA-070 compared to placebo on pain and inflammation induced by PDT. The primary objective is to detect a statistically significant difference of pain and inflammation i...
Eligibility Criteria
Inclusion
- Diagnosis ot actinic keratosis to be treated with PDT affecting equal sized areas of both sides of the head affecting at least 10% of the area of photoexposure
Exclusion
- Morpheaform basal cell carcinoma, Major hypertrophy of lesions, Porphyria, Topical treatment with 5-FU, cryotherapy, PDT, diclophenac sodium, and other less common treatments on the treatment area or systemic treatment within 3 month prior to screening, Concomitant use of other analgesics including topical NSAIDs
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00269074
Start Date
January 1 2006
End Date
July 1 2006
Last Update
March 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatological department of university hospital
Düsseldorf, North Rhine-Westphalia, Germany, D-40225